Cheorl-Ho KimCheorl-Ho Kim. 2020. Ganglioside Biochemistry. Ganglioside Biochemistry
193
214
.
Amene Saghazadeh & Nima Rezaei. 2020. Cancer Immunology. Cancer Immunology
305
332
.
Alexandra M. Haugh & Douglas B. Johnson. (2019) Management of V600E and V600K BRAF-Mutant Melanoma. Current Treatment Options in Oncology 20:11.
Crossref
Ke-Hua Li, Thomas Griffin, Neda Nikbakht, Le Qu, Hong-Duo Chen, Chundi He & Li-Xin Xia. 2017. Practical Immunodermatology. Practical Immunodermatology
279
296
.
Ryan J. Davey, Andre van der Westhuizen & Nikola A. Bowden. (2016) Metastatic melanoma treatment: Combining old and new therapies. Critical Reviews in Oncology/Hematology 98, pages 242-253.
Crossref
Martin J. D’Souza, Rikhav P. Gala, Ruhi V. Ubale, Bernadette D’Souza, Trinh Phuong Vo, Ashwin C. Parenky, Nihal S. Mulla, Sucheta D’Sa, Marissa D’Souza, Kim Braz-Gomes, Nigel D’Souza, Maurizio Chiriva-Internati & Susu Zughaier. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
89
122
.
Ravi A. Madan, Theresa A. Ferrara & James L. Gulley. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
553
568
.
Han-fang Mei, Xiao-bao Jin, Jia-yong Zhu, Ai-hua Zeng, Qiang Wu, Xue-mei Lu, Xiao-bo Li & Juan Shen. (2012) ?-defensin 2 as an Adjuvant Promotes Anti-Melanoma Immune Responses and Inhibits the Growth of Implanted Murine Melanoma In Vivo. PLoS ONE 7:2, pages e31328.
Crossref
Matthew T. Ballo & K. Kian Ang. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology
771
782
.
Katharina Amschler, Michael P. Schön, Nadin Pletz, Katrin Wallbrecht, Luise Erpenbeck & Margarete Schön. (2010) NF-κB Inhibition through Proteasome Inhibition or IKKβ Blockade Increases the Susceptibility of Melanoma Cells to Cytostatic Treatment through Distinct Pathways. Journal of Investigative Dermatology 130:4, pages 1073-1086.
Crossref
Alexander M.M. Eggermont. (2009) Immunostimulation Versus Immunosuppression after Multiple Vaccinations: the Woes of Therapeutic Vaccine Development. Clinical Cancer Research 15:22, pages 6745-6747.
Crossref
Ji-Wei Liu, Ping Sun, Qiu Yan, Amy S. Paller, Pedram Gerami, Nancy Ho, Neelam Vashi, I. Caroline Le Poole & Xiao-qi Wang. (2009)
De-
N
-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling–Dependent MMP-2 Activation
. Cancer Research 69:22, pages 8662-8669.
Crossref
D. Schadendorf, S.M. Algarra, L. Bastholt, G. Cinat, B. Dreno, A.M.M. Eggermont, E. Espinosa, J. Guo, A. Hauschild, T. Petrella, J. Schachter & P. Hersey. (2009) Immunotherapy of distant metastatic disease. Annals of Oncology 20, pages vi41-vi50.
Crossref
Alexander M.M. Eggermont. (2009) Therapeutic vaccines in solid tumours: Can they be harmful?. European Journal of Cancer 45:12, pages 2087-2090.
Crossref
Aude Bonehill, An M.T. Van Nuffel, Jurgen Corthals, Sandra Tuyaerts, Carlo Heirman, Violaine François, Didier Colau, Pierre van der Bruggen, Bart Neyns & Kris Thielemans. (2009) Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients. Clinical Cancer Research 15:10, pages 3366-3375.
Crossref